Subscribe

What are you looking for?

Main Menu

明報新聞網

和黃醫藥：Syk抑制劑取得陽性頂線結果

Future Wealths
Future Wealths
7 1 月, 2026
One Min Read
6 Views
0 Comments
和黃醫藥(0013)公布新型脾酪氨酸激酶（「Syk」）抑制劑索樂匹尼布用於治療溫抗體型自身免疫性溶血性貧血成人患者的ESLIM-02研究的III期註冊階段已達到第5至24周治療期間持久血紅蛋白（Hb）應答這一主要終點。

原文: https://finance.mingpao.com/fin/instantf/20260107/1767748759375/%e5%92%8c%e9%bb%83%e9%86%ab%e8%97%a5-syk%e6%8a%91%e5%88%b6%e5%8a%91%e5%8f%96%e5%be%97%e9%99%bd%e6%80%a7%e9%a0%82%e7%b7%9a%e7%b5%90%e6%9e%9c

Last Update: 7 1 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept